John Goldberg

John Goldberg

Company: Oncorus

Job title: Senior Vice President – Clinical Development


Viral Immunotherapy for Triple-Negative Breast Cancer 12:30 pm

• Viral immunotherapy can engender a potent immune response against both treated and untreated tumors and can overcome innate and acquired resistance to immunotherapy • Strategies for “heating up” triple-negative breast cancer both in the check point inhibitor resistant (PD-L1 negative) setting and in the case of progression (anti-PD-1 resistant) will meaningfully address this unmet…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.